BetaEntity Annotation Prototype
← Back to institutions

Annotated abstract

Type 1 diabetes: UK approves first drug for delaying onset

bmj · 2025-08-15 · canonical JSON source

4 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in patients who are in the early stages of the disease.